Found 65 matching trials
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma PHASE2 The purpose of this study is to evaluate the effectiveness and safety of th...
Show More Location
Zhongshan Hospital Fudan University
Learn More & Join Trial
BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors PHASE1 The primary objective of this study is to assess the safety and tolerabilit...
Show More Location
Icahn School of Medicine At Mount Sinai
Learn More & Join Trial
Predictive Biomarker for Efficacy and Safety of Combination of Chemotherapy and Tislelizumab in NSCLC PHASE2 To explore the related biomarkers for safety and efficacy of the combinatio...
Show More Location
Guangzhou Medical University Affiliated Cancer Hospital
Learn More & Join Trial
Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer PHASE2 This study aimed to evaluate the safety and effectiveness of ociperlimab co...
Show More Location
Valkyrie Clinical Trials
Learn More & Join Trial
Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma PHASE2 This study aims to investigate the efficacy and safety of low-dose radiatio...
Show More Location
Sichuan University West China Hospital
Learn More & Join Trial
Nephron-sparing Treatment of Tislelizumab + Nab-Paclitaxel for Renal Pelvic Cancer PHASE2 This study is designed as an open-label, single-arm, single-center, phase I...
Show More Location
The Second Hospital of Tianjin Medical University
Learn More & Join Trial
SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC PHASE2 The aim of this clinical trial is to understand whether spatial fractionate...
Show More Location
Nanchang City, Jiangxi Province
Learn More & Join Trial
Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC PHASE2 This phase II trial employs a prospective, randomized, parallel-group desig...
Show More Location
Sun yat-sen University Cancer Center
Learn More & Join Trial
Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer N/A This is a multicenter Phase 1b/2 clinical trial investigating the efficacy ...
Show More Location
CHA Bundang Medical Center
Learn More & Join Trial
A Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer PHASE3 An open-label, randomized, multicenter Phase 3 study designed to compare th...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial